» Articles » PMID: 35432206

Induction of Collagen I by CXCL10 in Ovarian Theca-Stroma Cells the JNK Pathway

Overview
Specialty Endocrinology
Date 2022 Apr 18
PMID 35432206
Authors
Affiliations
Soon will be listed here.
Abstract

Premature ovarian insufficiency (POI) poses a great threat to reproductive-age women. Ovarian fibrogenesis is a basic histologic feature of POI. Ovarian theca-stroma cells are responsible for ovarian fibrosis, but few studies have focused on the ovarian microenvironment. The role and mechanism of chemokines in the development of POI remain unclear. Here, we evaluated C-X-C motif chemokine ligand 10 (CXCL10) in biochemical POI patients, POI patients, and a POI mouse model. CXCL10 levels in serum and follicular fluid were higher in both bPOI and POI patients than in controls. An increased level of CXCL10 was also observed in a POI mouse model. CXCL10 concentrations in serum and follicular fluid were positively associated with follicle-stimulating hormone and negatively associated with antral follicle count. Our study for the first time found that CXCL10 induced COL1A1 and COL1A2 production, two subunits of collagen I in mouse theca-stroma cells by activating the JNK/c-Jun pathway. Inhibition of JNK and c-Jun attenuated the increases of COL1A1 and COL1A2 caused by CXCL10. Moreover, CXCL10 had no effects on hormone synthesis, proliferation, and apoptosis in human luteinized granulosa (hGL) cells. Our findings revealed a potential diagnostic value of CXCL10 in the early stage of POI and shed new insights into the biological function of CXCL10 in ovarian fibrosis.

Citing Articles

Redox Balance and Inflammatory Response in Follicular Fluids of Women Recovered by SARS-CoV-2 Infection or Anti-COVID-19 Vaccinated: A Combined Metabolomics and Biochemical Study.

Castiglione Morelli M, Iuliano A, Viggiani L, Matera I, Pistone A, Schettini S Int J Mol Sci. 2024; 25(15).

PMID: 39125969 PMC: 11313332. DOI: 10.3390/ijms25158400.


Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion.

Zhao M, Liao B, Yun C, Qi X, Pang Y Reprod Biol Endocrinol. 2024; 22(1):98.

PMID: 39107809 PMC: 11302332. DOI: 10.1186/s12958-024-01269-9.


CXCL10-based gene cluster model serves as a potential diagnostic biomarker for premature ovarian failure.

Qin Y, Wen C, Wu H PeerJ. 2023; 11:e16659.

PMID: 38107572 PMC: 10725173. DOI: 10.7717/peerj.16659.


New Gene Markers of Exosomal Regulation Are Involved in Porcine Granulosa Cell Adhesion, Migration, and Proliferation.

Kulus J, Kranc W, Kulus M, Bukowska D, Piotrowska-Kempisty H, Mozdziak P Int J Mol Sci. 2023; 24(14).

PMID: 37511632 PMC: 10380331. DOI: 10.3390/ijms241411873.


Single-cell RNA sequencing of peripheral blood reveals immune cell dysfunction in premature ovarian insufficiency.

Zhang C, Yu D, Mei Y, Liu S, Shao H, Sun Q Front Endocrinol (Lausanne). 2023; 14:1129657.

PMID: 37223018 PMC: 10200870. DOI: 10.3389/fendo.2023.1129657.

References
1.
Johnson J, Canning J, Kaneko T, Pru J, Tilly J . Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004; 428(6979):145-50. DOI: 10.1038/nature02316. View

2.
Yang Z, Tang Z, Cao X, Xie Q, Hu C, Zhong Z . Controlling chronic low-grade inflammation to improve follicle development and survival. Am J Reprod Immunol. 2020; 84(2):e13265. DOI: 10.1111/aji.13265. View

3.
Silva C, Yamakami L, Aikawa N, Araujo D, Carvalho J, Bonfa E . Autoimmune primary ovarian insufficiency. Autoimmun Rev. 2014; 13(4-5):427-30. DOI: 10.1016/j.autrev.2014.01.003. View

4.
Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B . ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016; 31(5):926-37. DOI: 10.1093/humrep/dew027. View

5.
Vander Borght M, Wyns C . Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018; 62:2-10. DOI: 10.1016/j.clinbiochem.2018.03.012. View